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Two clerodane diterpenoids, Bafoudiosbulbins A 1, and B 2, together with ﬁve known compounds: tetracosanoic acid, 1-(tetracosa-
noyl)-glycerol, trans-tetracosanylferulate, b-sitosterol and 3-O-b-D-glucopyranosyl-b-sitosterol were isolated from the tubers of Diosco-
rea bulbifera L. var sativa. Their structures were established by spectroscopic methods (1D and 2D-NMR, MS) and X-ray
crystallographic diﬀraction analysis of compound 1. The CH2Cl2-soluble portion of the crude extract and the two clerodanes were
screened for anti-bacterial activity using both agar diﬀusion and broth dilution techniques against Pseudomonas aeruginosa, Escherichia
coli, Klebsiella pneumoniae, Staphylococcus aureus, Salmonella typhi, Salmonella paratyphi A and Salmonella paratyphi B. They both
showed signiﬁcant activities against P. aeruginosa, S. typhi, S. paratyphi A and S. paratyphi B.
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Dioscorea bulbifera L. var sativa (Dioscoreaceae) usually
grows wild and its bitter tubers are used by tribal people in
Bangladesh for the treatment of leprosy and tumors (Mur-
ray et al., 1984). Earlier chemical investigation of its tubers
aﬀorded two norclerodane diterpenoids (Murray et al.,
1984). Clerodane class of diterpenes is a group of com-
pounds that has attracted considerable interest because of
problems associated with their stereochemistry and because
of the diverse biological activities shown by some members
(Roengsunran et al., 2002; Komori, 1997; Ortega et al.,
1982; Fayos et al., 1984). They are known to possess* Corresponding author. Tel.: +237 500 48 26; fax: +237 345 17 35.
E-mail address: tapondjou2001@yahoo.fr (A.L. Tapondjou).anti-tumor, anti-bacterial, anti-feedant, anti-fungal and
hallucinogenic activities (Urones et al., 1995; Biswanath
et al., 2005; Harding et al., 2006). In our continuous search
of potentially interesting novel and/or known compounds
from Cameroonian medicinal plants (Tapondjou et al.,
2003; Tapondjou et al., 2005; Djoukeng et al., 2005), we
have examined the extract from the tubers of D. bulbifera
L. var sativa growing in the western highlands of Camer-
oon for its anti-typhoid activity. Typhoid fever is caused
by Salmonella typhi, whereas paratyphoid fevers are caused
by Salmonella paratyphi A and Salmonella paratyphi B
(Cheesbrough, 1991; Gatsing et al., 2006). Typhoid fever
continues to be a marked public health problem in develop-
ing countries in general and in Sub-saharan Africa in par-
ticular, where it is endemic. The greater prevalence of
resistance to all three ﬁrst-line anti-microbials (ampicillin,
chloramphenicol and co-trimoxazole) has been established
2(WHO, 1981). This paper deals with the bioassay-guided
isolation and structural elucidation of two new anti-
salmonellal clerodane diterpenoids together with the
known tetracosanoic acid, 1-(tetracosanoyl)-glycerol,
trans-tetracosanylferulate, b-sitosterol and 3-O-b-D-gluco-
pyranosyl-b-sitosterol from the extract of the tubers of D.
bulbifera L. var sativa. The anti-microbial activity of the
extract and the above two clerodanes was investigated
against several bacteria among which S. typhi, S. paratyphi
A and S. paratyphi B.2. Results and discussion
The air-dried and pulverized tubers of D. bulbifera L.
var sativa were extracted with 80% MeOH at room temper-
ature for 24 h followed by heating for 20 min. The aqueous
methanolic extract was concentrated under reduced pres-
sure to yield a dark residue which was suspended in water
and submitted to successive partition with CH2Cl2 and n-
butanol. The CH2Cl2 soluble portion was fractionated
and chromatographed repeatedly on silica gel and sepha-
dex LH-20 columns to give two new clerodane diterpenoids
1 and 2 together with the known tetracosanoic acid (Salas
et al., 2005), 1-(tetracosanoyl)-glycerol (Sultana et al.,
1999), trans-tetracosanylferulate (Jih-Jung et al., 2004), b-
sitosterol (Flamini et al., 2001) and 3-O-b-D-glucopyrano-
syl-b-sitosterol (Flamini et al., 2001).
Compound 1 was isolated as white needles in MeOH,
m.p.: 252.8 C, ½a21D 64.6 (c 0.025, DMSO). Its HRESIMS
(positive mode) displayed a pseudomolecular ion peak atTable 1
1H and 13C NMR data in DMSO, COSY and HMBC correlations of compou
C/H atom d 13C (ppm) DEPT d 1H (m
1 27.5 CH2 1.72 m
2.21 m
2 74.3 CH 4.89 m
3 31.0 CH2 2.15 m
2.18 m
4 39.5 CH 3.65 nd
5 46.2 C /
6 75.0 CH 4.85 brd
7 32.6 CH2 2.64 dd
2.49 d (
8 88.9 C /
9 46.6 C /
10 38.8 CH 2.08 brd
11 43.9 CH2 1.89 dd
2.00 dd
12 75.0 CH 5.30 dd
13 126.4 C /
14 111.2 CH 6.82 brs
15 143.9 CH 7.60 brs
16 141.9 CH 7.68 brs
17 177.4 C /
18 173.2 C /
19 171.0 C /
20 18.7 CH3 1.38 s
21 53.3 CH3 3.67 s
nd: not determined.m/z 425.12071 [M + Na]+ corresponding to the molecular
formula C21H22O8 (calc. 425.12). This was conﬁrmed by
the ESIMS (positive mode) which showed the pseudomo-
lecular ion peak at m/z 403 [M + H]+ and two important
peaks at m/z 375 [M + H  CO]+ and 357 [M + H 
CO  H2O]+. Compound 1 exhibited also in its IR spec-
trum two particularly broad and intense bands at 1741
and 1787 cm1 which are characteristic of d-lactone and
c-lactone, respectively (Murray et al., 1984) and another
band at 875 cm1 suggesting the presence of a furan moi-
ety. The 100 MHz 13C NMR of 1 exhibited 21 signals, con-
ﬁrming the mass data. Signals for three methines at d 143.9
(C-15), 141.9 (C-16) and 111.2 (C-14) are characteristic of
furoclerodanes (Kapingu et al., 2000). The last furan car-
bon signal was observed at d 126.4 (C-13). Other salient
features of this spectrum were three deshielded quaternary
signals of the ester type at d 177.4 (C-17), 173.2 (C-18) and
171.0 (C-19). The remaining peaks were due to two methyl,
four methylene, ﬁve methine groups and three quaternary
carbons (Table 1).
The 400 MHz 1H NMR spectrum of compound 1 dis-
played three furan signals at d 7.68 (1H, brs, H-16), 7.60
(1H, brs, H-15), 6.82 (1H, brs, H-14), and two methyl peaks
at d 3.67 (3H, s, H-21) and 1.38 (3H, s, H-20). Furthermore,
three downﬁeld signals were observed at d 5.30 (1H, dd,
J = 5.0, 10.9 Hz, H-12), 4.89 (1H, m, H-2) and 4.85 (1H,
brd, J = 5.3 Hz, H-6) corresponding to three oxygenated
methines. The complete assignments of all 1H and 13C res-
onances were achieved by COSY, HSQC, and HMBC
(Table 1). Final proof of the structure and stereochemistry
of compound 1 was obtained from a single crystal X-raynd 1
ult, J (Hz)) COSY (HMH) HMBC (C! H)
Ha-3, Hb-3
H-2
H-6
(5.3) Ha-7, Hb-7
(5.3, 12.4) Ha-7
12.4) Hb-7
H-20, H-6, Hb-7
H-20, H-12, H-6
(7.8) Ha-1, Hb-1
(10.9, 11.4) Hb-11
(5.0, 11.4)
(5.0, 10.9) Ha-11, Hb-11 Hb-7
H-16, H-12, H-14
H-15 H-15, H-12
H-14 H-14
H-15, H-12, H-14
Ha-7, H-6
H-21
H-2
3analysis using direct methods. The ORTEP diagram of the
crystal structure of this compound (Fig. 1) clearly shows
that the c-lactone ring bridging C-6 and C-8, the d-lactone
ring bridging C-2 and C-5, the carboxymethyl group at C-4
and the furan moiety are placed on the a face of the mole-
cule. It also shows that the proton H-10 and the methyl
group C-20 have the a and b-orientations, respectively.
Compound 1 is then elucidated as methyl 8,12R,15,16-diep-
oxyclerodane-13(16),14-diene-17,6a;19,2a-diolide 18-oate.
To the best of our knowledge its structure has not been
reported previously.O
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20Compound 2 was isolated as white crystals in MeOH,
m.p.: 312.9 C, ½a21D +52 (c 0.010, pyridine). Its ESI mass
spectrum (negative mode) displayed a molecular ion peak
at m/z 387 [M  H] establishing the formula C20H20O8,
and two important peaks at m/z 343 [M  H  CO2]
and 329 [M  H  CO  CH2O]. The IR spectrum of 2
was almost superimposable to that of 1, the only diﬀerence
being the presence of an intense band at 3428 cm1, charac-
teristic of hydroxyl group in compound 2. The 13C NMR
spectrum of compound 2 was very informative because it
revealed the presence of 20 resonances. Among these, threeFig. 1. ORTEP diagram of the crycarbonyl groups of the lactone type were observed at d
172.1 (C-17), 172.5 (C-19) and 175.1 (C-18). Four signals
observed at d 144.6 (C-15), 141.1 (C-16), 125.7 (C-13) and
109.5 (C-14) are characteristic of furoclerodanes (Kapingu
et al., 2000; Tane et al., 1997; Fayos et al., 1984). Combina-
tion of 13C NMR and DEPT spectra showed the presence of
7 methines, 6 methylenes and 7 quaternary carbons. Signals
at d 73.8 (C-2), 70.8 (C-12), 74.7 (C-8) and 67.5 (C-20) indi-
cated the presence of two oxygenated methine groups, one
oxygenated quaternary carbon and one hydroxymethylene
group, respectively.The 400 MHz 1H NMR spectrum of 2 displayed, in
addition to the furan signals [d 7.70 (1H, d, J = 0.7 Hz,
H-16); 7.51 (1H, d, J = 1.7 Hz, H-15), 6.57 (1H, dd,
J = 1.7, 0.7 Hz, H-14)], one extra AB system of two pro-
tons at d 4.72 (1H, d, J = 13.7 Hz) and 4.55 (1H, d,
J = 13.7 Hz) ascribed to the two non-equivalent protons
of the hydroxymethylene group at C-20. Furthermore,
two downﬁeld signals integrating each for one proton were
observed at d 4.88 (1H, m, H-2) and 5.50 (1H, dd, J = 12.7,
3.4 Hz, H-12) corresponding to two oxygenated methine
protons. Proximity relationships between 1H–1H werestal structure of compound 1.
Table 2
1H and 13C NMR data in C5H5N-d5, COSY and HMBC correlations of compound 2
Positions d 13C (ppm) DEPT d 1H (mult, J (Hz)) COSY (HMH) HMBC (C!H)
1 27.1 CH2 1.95 m H-2, H-10
2.30 m
2 73.8 CH 4.88 m Ha-3, Hb-3
3 27.5 CH2 2.16 m H-4
2.51 m
4 45.1 CH 3.46 dd (12.5, 7.3) Ha-3, Hb-3 H-1, Ha-6, Hb-3
5 44.2 C / H-20, Ha-7, Hb-11
6 27.3 CH2 2.10 m Ha-7
2.30 m
7 28.9 CH2 2.42 m Ha-6, Hb-6
3.10 m Ha-6, Hb-6
8 74.7 C / Ha-7, Hb-11, H-20
9 40.2 C / Ha-7, Ha-6, H-4
10 36.5 CH 2.60 brd (9.8) Ha-1, Hb-1 Hb-11, H-4, H-2
11 30.6 CH2 1.70 dd (14.1, 3.4) Hb-11 H-20
2.70 dd (14.1, 12.7)
12 70.8 CH 5.50 dd (12.7, 3.4) Ha-11, Hb-11 Hb-11
13 125.7 C / H-12, Hb-11, H-14, H-16
14 109.5 CH 6.57 dd (1.7, 0.7) H-15 H-12, H-15, H-16
15 144.6 CH 7.51 d (1.7) H-14 H-14
16 141.1 CH 7.70 d (0.7) H-14
17 172.1 C / H-20, Hb-7, Ha-7
18 175.1 C / H-2, H-4, Hb-3
19 172.5 C / H-4, Hb-3
20 67.5 CH2 4.55 d (13.7) H-10, Hb-11
4.72 d (13.7)
4achieved by COSY experiment while direct C! H correla-
tions were established using the HSQC spectrum data
(Table 2). The HMBC sequence provided information on
the long-range connectivities between various 1H and 13C
atoms. It showed 2J, 3J and 4J interactions between H-4
(d 3.46) and C-19, C-18, C-10, C-9 and C-3, between H-2
(d 4.88) and C-18, C-10 and C-4, between Hb-11 (d 2.70)
and C-5, C-8, C-10, C-12 and C-20. Many other correla-
tions were also observed (Table 2). The C-12 conﬁguration
was deduced from careful comparison of the 1H and 13C
data with those of related compounds (Kapingu et al.,
2000; Fayos et al., 1984; Ortega et al., 1982; Murray
et al., 1984). This was corroborated by the axial nature
of H-12 which showed couplings of 12.7 and 3.4 Hz toFig. 2. Signiﬁcant NOESY correlations for compound 2.the axial and equatorial protons at C-11, respectively
(Murray et al., 1984). The relative stereochemistry of 2
was determined by NOESY experiment. Signiﬁcant corre-
lations were depicted on its NOESY spectrum (Fig. 2)
between H-12 (d 5.50) and H-10 (d 2.60), H-10 and H-2
(d 4.88), H-10 and H-4 (d 3.46), H-4 and Ha-3 (d 2.51),
Ha-3 and H-2, H-2 and Ha-1 (d 2.30). The interaction
between Hb-1 (d 1.95) and one of the C-20 hydroxymethyl-
ene protons (d 4.72) allowed us to deduce the C-9 conﬁgu-
ration. The inspection of the structure of 2 made by
molecular model suggested that such NOESY correlations
are expected when the d-lactone ring bridging C-5 and C-8
is placed on the b face of the molecule (Fig. 2). Conse-
quently, compound 2 is 15,16-epoxy-20-hydroxyclero-
dane-13(16),14-diene-17,12S;18,2b;19,8b-triolide and to
the best of our knowledge, its structure is hereby reported
for the ﬁrst time.
The various extracts (crude aqueous methanolic extract,
CH2Cl2 extract and the n-butanol extract) were initially
tested against Pseudomonas aeruginosa, Escherichia coli,
Klebsiella pneumoniae, Staphylococcus aureus, S. typhi, S.
paratyphi A and S. paratyphi B. The n-butanol extract
showed no activity against all the seven bacteria strains,
whereas the crude aqueous methanolic extract showed very
weak activity against P. aeruginosa, S. typhi, S. paratyphi A
and S. paratyphi B and no activity against E. coli, K. pneu-
moniae and S. aureus. The CH2Cl2 extract showed remark-
able activity against P. aeruginosa, S. typhi, S. paratyphi A
and S. paratyphi B and no activity against E. coli, K. pneu-
moniae and S. aureus (Table 3). Thereafter the CH2Cl2
Table 3
Diameters of inhibition of Salmonella typhi, Salmonella paratyphi A, Salmonella paratyphi B, Pseudomonas aeruginosa, Escherichia coli, Klebsiella
pneumoniae, Staphylococcus aureus by the CH2Cl2-extract and compounds 1 and 2
Disc potency Bacteria and diameters of zones of inhibition (mm)
ST SPA SPB PA EC SA KP
CH2Cl2-extract 5 mg 7 7 12 9 NA NA NA
Compound 1 100 lg 13 11 9 12 NA NA NA
Compound 2 100 lg 11 13 9 15 NA NA NA
Chloramphenicol 100 lg 18 20 25 NT NT NT NT
Amoxicillin 100 lg NT NT NT 18 17 19 14
Key. NA = not active, NT = not tested.
ST: Salmonella typhi, SPA: Salmonella paratyphi A, SPB: Salmonella paratyphi B, PA: Pseudomonas aeruginosa, EC: Escherichia coli, KP: Klebsiella
pneumoniae, SA: Staphylococcus aureus.
5extract was fractionated and puriﬁed to yield mainly com-
pounds 1 and 2 which were also tested against all the seven
bacteria strains. The data obtained showed that com-
pounds 1 and 2 were also very active against P. aeruginosa,
S. typhi, S. paratyphi A and S. paratyphi B (Table 3).
Compounds 1 and 2, which showed anti-bacterial activ-
ity against P. aeruginosa, S. typhi, S. paratyphi A and S.
paratyphi B were further studied using broth dilution tech-
nique in order to determine the MIC (Minimum Inhibitory
Concentration) and MBC (Minimum Bactericidal Concen-
tration) values (Table 4).
Anti-microbial substances are considered as bacterici-
dal agents when the ratio MBC/MIC 6 4 and bacterio-
static agents when the ratio MBC/MIC > 4 (Carbonnelle
et al., 1987; Gatsing et al., 2006). For compounds 1 and
2, these ratios were 64 (Table 4) suggesting that they
may be classiﬁed as bactericidal agents. All these results
suggest that the CH2Cl2 extract and the two new clerod-
anes essentially exhibited anti-salmonellal activity, thus
indicating that this plant could be used in the treatment
of typhoid fevers.Table 4
Inhibition parameters (MIC, MBC) of the isolated compounds against
Salmonella typhi, Salmonella paratyphi A, Salmonella paratyphi B and
Pseudomonas aeruginosa
Parameters Bacteria strains
ST SPA SPB PA
Compound 1 MIC (lg/ml) 50 50 25 50
MBC (lg/ml) 200 100 100 200
MBC/MIC 4 2 4 4
Compound 2 MIC (lg/ml) 50 25 25 25
MBC (lg/ml) 200 100 100 100
MBC/MIC 4 4 4 4
Chloramphenicol MIC (lg/ml) 2.5 2.5 2.5 /
MBC (lg/ml) 20 20 20 /
MBC/MIC 8 8 8 /
Amoxicillin MIC (lg/ml) / / / 12.5
MBC (lg/ml) / / / 25
MBC/MIC / / / 2
Key. ST: Salmonella typhi, SPA: Salmonella paratyphi A, SPB: Salmonella
paratyphi B, PA: Pseudomonas aeruginosa, MIC: minimum inhibitory
concentration; MBC: minimum bactericidal concentration.3. Experimental
3.1. General experimental procedures
Melting points were determined using the Gallenkamp
Melting Point Apparatus. Optical rotations were measured
on a Perkin–Elmer 241 Polarimeter, IR spectra were mea-
sured as a ﬁlm on a KBr pellet using a FTIR-8400S Shima-
dzu spectrometer. HRESIMS were taken on the mass
spectrometer Brucker FTMS4.7T, BIOAPEXII. 1H NMR
spectra were recorded in deuterated solvents (DMSO and
C5H5N) on a Brucker AMX-400 Spectrometer at 400 MHz
while 13C NMR spectra were recorded in the same solvents
and the same apparatus at 100 MHz. All chemical shifts
(d) are given in ppm units with reference to tetramethylsilane
(TMS) as internal standard and the coupling constants (J)
are inHz.Column chromatographywas performed using sil-
ica gel 60 Merck (0.040–0.063 mm) and sephadex LH-20.
TLC were carried out on precoated Kieselgel 60 F254
(Merck) plates developed with hexane:AcOEt (7:3 or 1:1)
and AcOEt:MeOH (98:2 or 95:5). TLC plates were viewed
with an ultraviolet lamp MULTIBAND UV-254/365 nm
for ﬂuorescent spots. They were also visualised by spraying
with 50% H2SO4 and heating for 10 min at 110 C.
3.2. Plant material
The tubers of D. bulbifera L. var sativa were collected in
Bafou village near Dschang (West province of Cameroon)
in March 2005. Specimens documenting the collection are
deposited in the Cameroon National Herbarium in Yao-
unde´ (Ref.: 22211/SRF/CAM).
3.3. Test bacteria and culture media
The test microorganisms, P. aeruginosa, E. coli, K. pneu-
moniae, S. aureus, S. typhi, S. paratyphi A and S. paratyphi
B, were obtained from the Medical Bacteriology Labora-
tory of Pasteur Centre, Yaounde´, Cameroon. The culture
media used, namely Nutrient agar and Nutrient Broth
(used for the culture of P. aeruginosa, E. coli, K. pneumo-
niae and S. aureus), Salmonella-Shigella agar (SS agar)
and Selenite Broth (for culture of S. typhi, S. paratyphi A
6and S. paratyphi B) were supplied by International Diag-
nostics Group PLC, Topley House, 52 Wash Lane, Bury,
Lancashire BL9 6AU, UK.
3.4. Anti-microbial assay
The anti-bacterial activity was determined using both
agar diﬀusion and broth dilution techniques as previously
described by Cheesbrough (1991) and Gatsing et al. (2006).
Agar diﬀusion susceptibility testing was done using the
disc method. A disc of blotting paper was impregnated
with 10 ll of a 500 mg/ml (for crude extract) or 10 mg/ml
(for pure compounds) solution of each sample dissolved
in DMSO. Thus the disc potencies were 5 mg and 100 lg
for crude extract and pure compounds, respectively.
Amoxicillin and chloramphenicol (Sigma) were used as
the standard drugs. After drying, the disc was placed on
a plate of sensitivity testing agar inoculated with the test
organism. The petridishes were left at room temperature
for about 45 min to allow the extract or the compounds
to diﬀuse from the disc into the medium. They were then
incubated at 37 C for 24 h, after which the zones of no
growth were noted and their diameters recorded as the
zones of inhibition.
For the broth dilution susceptibility testing, the solu-
tions (maximum concentration) of the active compounds
(i.e. the compounds that induced zones of inhibition) were
prepared in DMSO, serially (2-fold) diluted and 0.5 ml of
each dilution was introduced into a test tube containing
4.4 ml of Selenite broth; then 0.1 ml of bacteria suspension
(5 · 105 cfu/ml) was added and the mixture was homoge-
nized. The total volume of the mixture was 5 ml, with the
test-compound concentrations in the tube ranging from
200 to 6.25 lg/ml and those of the standard compounds,
i.e. amoxicillin and chloramphenicol, ranging from 100 to
3.125 lg/ml and 40 to 0.625 lg/ml, respectively. After
24 h of incubation at 37 C, the MIC was reported as the
lowest concentration of anti-microbial that prevented visi-
ble growth. The MBC was determined by sub-culturing the
last tube to show visible growth and all the tubes in which
there was no growth on already prepared plates containing
nutrient agar or SS agar medium. The plates were then
incubated at 37 C for 24 h and the lowest concentration
showing no growth was taken as the MBC.
3.5. Extraction and isolation
The air-dried tubers of D. bulbifera L. var sativa (1.8 kg)
were pulverized and extracted four times (each time for
24 h followed by heating for 20 min) with 80% MeOH.
The aqueous methanolic extract was concentrated under
reduced pressure to yield a dark residue (75 g), which was
suspended in water (200 ml) and submitted to successive
partition with CH2Cl2 and n-butanol. The CH2Cl2 soluble
portion (33.5 g) was subjected to column chromatography
over silica gel. Elution using hexane, hexane–EtOAc mix-
tures, EtOAc–MeOH mixtures and MeOH aﬀorded 10main fractions, A–J. From fraction G (hexane–EtOAc
40%) (4.00 g), Bafoudiosbulbins A (450 mg) and B
(410 mg) were obtained after further puriﬁcation over silica
gel (eluted with hexane–EtOAc 1–1) and sephadex (eluted
with CH2Cl2–MeOH 1–1) column chromatography fol-
lowed by recrystallisation with MeOH. Successive column
chromatography over silica gel of fraction B (hexane–
EtOAc 10%) (6.00 g) using hexane–EtOAc 9–1, 9–2 and
9–3 aﬀorded tetracosanoic acid (50 mg), trans-tetracosanyl-
ferulate (25 mg) and b-sitosterol (150 mg), respectively.
Column chromatography of fraction D (hexane–EtOAc
20%) (5.50 g) over silica gel (eluted with hexane–EtOAc
7–3) yielded 1-(tetracosanoyl)-glycerol (230 mg) while 3-
O-b-D-glucopyranosyl-b-sitosterol (100 mg) was obtained
as white powder after recrystallisation of fraction I
(EtOAc) (1.5 g).3.6. X-ray crystallographic analysis of Bafoudiosbulbin A
Suitable crystals of Bafoudiosbulbin A were obtained as
colourless rods from a chloroform/methanol/acetone solu-
tion. The compound crystallized in the chiral orthorhombic
space group P212121. Crystal data: C21H22O8, M = 402.
The intensity data were collected at 173 K (100 C) on
a Stoe Mark II-Image Diﬀraction System equipped with
a two-circle goniometer and using MoKa graphite mono-
chromated radiation. Image plate distance 100 mm, x rota-
tion scans 0–180 at / 0, 0–74 at / 90, step qx = 1.0,
with an exposure time of 4 min per image, 2h range 2.29–
59.53, dmin  dmax = 17.779–0.716 A˚. The structure was
solved by direct method using the program SHELXS.
The reﬁnement and all further calculations were carried
out using SHELXL-97. The H-atoms were included in cal-
culated positions and treated as riding atoms using
SHELXL default parameters. The non-H atoms were
reﬁned anisotropically, using weighted full-matrix least-
squares on F2.3.7. Compound 1: Bafoudiosbulbin A
White needles, m.p. 252.8 C (MeOH); ½a21D 64.6 (c
0.025, DMSO); IR mmax (KBr) cm
1: 2916, 1787, 1741,
1062, 875; 1H NMR (DMSO, 400 MHz): Table 1; 13C
NMR (DMSO, 100 MHz): Table 1; HRESIMS: m/z
425.12071 [M + Na]+; ESIMS: m/z (rel. int.) 403 [M + H]+
(25), 375 [M + H  CO]+ (90), 357 [M + H  CO  H2O]+
(10).3.8. Compound 2: Bafoudiosbulbin B
White crystals, m.p. 312.9 C (MeOH); ½a21D +52 (c
0.010, pyridine); IR mmax (KBr) cm
1: 3428, 2949, 1786,
1758, 1024, 874; 1H NMR (pyridine, 400 MHz): Table 2;
13C NMR (pyridine, 100 MHz): Table 2; ESIMS: m/z
(rel. int.) 387 [M  H] (100), 343 [M  H  CO2] (10),
329 [M  H  CO  CH2O] (30).
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